The role of radiomics in tongue cancer: A new tool for prognosis prediction.


Journal

Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541

Informations de publication

Date de publication:
04 2023
Historique:
revised: 08 11 2022
received: 01 07 2022
accepted: 27 12 2022
pubmed: 14 2 2023
medline: 16 3 2023
entrez: 13 2 2023
Statut: ppublish

Résumé

Radiomics represents an emerging field of precision-medicine. Its application in head and neck is still at the beginning. Retrospective study about magnetic resonance imaging (MRI) based radiomics in oral tongue squamous cell carcinoma (OTSCC) surgically treated (2010-2019; 79 patients). All preoperative MRIs include different sequences (T1, T2, DWI, ADC). Tumor volume was manually segmented and exported to radiomic-software, to perform feature extraction. Statistically significant variables were included in multivariable analysis and related to survival endpoints. Predictive models were elaborated (clinical, radiomic, clinical-radiomic models) and compared using C-index. In almost all clinical-radiomic models radiomic-score maintained statistical significance. In all cases C-index was higher in clinical-radiomic models than in clinical ones. ADC provided the best fit to the models (C-index 0.98, 0.86, 0.84 in loco-regional recurrence, cause-specific mortality, overall survival, respectively). MRI-based radiomics in OTSCC represents a promising noninvasive method of precision medicine, improving prognosis prediction before surgery.

Sections du résumé

BACKGROUND
Radiomics represents an emerging field of precision-medicine. Its application in head and neck is still at the beginning.
METHODS
Retrospective study about magnetic resonance imaging (MRI) based radiomics in oral tongue squamous cell carcinoma (OTSCC) surgically treated (2010-2019; 79 patients). All preoperative MRIs include different sequences (T1, T2, DWI, ADC). Tumor volume was manually segmented and exported to radiomic-software, to perform feature extraction. Statistically significant variables were included in multivariable analysis and related to survival endpoints. Predictive models were elaborated (clinical, radiomic, clinical-radiomic models) and compared using C-index.
RESULTS
In almost all clinical-radiomic models radiomic-score maintained statistical significance. In all cases C-index was higher in clinical-radiomic models than in clinical ones. ADC provided the best fit to the models (C-index 0.98, 0.86, 0.84 in loco-regional recurrence, cause-specific mortality, overall survival, respectively).
CONCLUSION
MRI-based radiomics in OTSCC represents a promising noninvasive method of precision medicine, improving prognosis prediction before surgery.

Identifiants

pubmed: 36779382
doi: 10.1002/hed.27299
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

849-861

Informations de copyright

© 2023 The Authors. Head & Neck published by Wiley Periodicals LLC.

Références

Keek SA, Leijenaar RT, Jochems A, Woodruff HC. A review on radiomics and the future of theranostics for patient selection in precision medicine. Br J Radiol. 2018;91(1091):20170926. doi:10.1259/bjr.20170926
Aerts HJ. The potential of radiomic-based phenotyping in precision medicine: a review. JAMA Oncol. 2016;2(12):1636-1642. doi:10.1001/jamaoncol.2016.2631
Aerts HJ, Velazquez ER, Leijenaar RT, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4644. doi:10.1038/ncomms5006
Song J, Yin Y, Wang H, Chang Z, Liu Z, Cui L. A review of original articles published in the emerging field of radiomics. Eur J Radiol. 2020;127:108991. doi:10.1016/j.ejrad.2020.108991
Peng Z, Wang Y, Wang Y, et al. Application of radiomics and machine learning in head and neck cancers. Int J Biol Sci. 2021;17(2):475-486. doi:10.7150/ijbs.55716
Jethanandani A, Lin TA, Volpe S, et al. Exploring applications of radiomics in magnetic resonance imaging of head and neck cancer: a systematic review. Front Oncol. 2018;14(8):131. doi:10.3389/fonc.2018.00131
Mahajan A, Ahuja A, Sable N, Stambuk HE. Imaging in oral cancers: a comprehensive review. Oral Oncol. 2020;104:104658. doi:10.1016/j.oraloncology.2020.104658
Moreira MA, Lessa LS, Bortoli FR, et al. Meta-analysis of magnetic resonance imaging accuracy for diagnosis of oral cancer. PLoS One. 2017;12(5):e0177462. doi:10.1371/journal.pone.0177462
National Comprehensive Cancer Network. Head and Neck Cancers (version 02.2022). Accessed June 11, 2022. http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf
Cohen EEW, Bell RB, Bifulco CB, et al. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC). J Immunother Cancer. 2019;7(1):184. doi:10.1186/s40425-019-0662-5
Bello IO, Soini Y, Salo T. Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I). Oral Oncol. 2010;46(9):630-635. doi:10.1016/j.oraloncology.2010.06.006
Brenner H. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet. 2002;360(9340):1131-1135. doi:10.1016/S0140-6736(02)11199-8
Zanoni DK, Montero PH, Migliacci JC, et al. Survival outcomes after treatment of cancer of the oral cavity (1985-2015). Oral Oncol. 2019;90:115-121. doi:10.1016/j.oraloncology.2019.02.001
Lenze NR, Farquhar DR, Dorismond C, et al. Age and risk of recurrence in oral tongue squamous cell carcinoma: systematic review. Head Neck. 2020;42(12):3755-3768. doi:10.1002/hed.26464
Faisal M, Dhanani R, Ullah S, et al. Prognostic outcomes of treatment naïve oral tongue squamous cell carcinoma (OTSCC): a comprehensive analysis of 14 years. Eur Arch Otorhinolaryngol. 2021;278(8):3045-3053. doi:10.1007/s00405-020-06482-x
Oliver JR, Wu SP, Chang CM, et al. Survival of oral tongue squamous cell carcinoma in young adults. Head Neck. 2019;41(9):2960-2968. doi:10.1002/hed.25772
Cooper JS, Pajak TF, Forastiere AA, et al. Radiation Therapy Oncology Group 9501/Intergroup. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350(19):1937-1944. doi:10.1056/NEJMoa032646
Tam S, Amit M, Zafereo M, Bell D, Weber RS. Depth of invasion as a predictor of nodal disease and survival in patients with oral tongue squamous cell carcinoma. Head Neck. 2019;41(1):177-184. doi:10.1002/hed.25506
Mannelli G, Comini LV, Piazza C. Surgical margins in oral squamous cell cancer: intraoperative evaluation and prognostic impact. Curr Opin Otolaryngol Head Neck Surg. 2019;27(2):98-103. doi:10.1097/MOO.0000000000000516
Ganly I, Patel S, Shah J. Early stage squamous cell cancer of the oral tongue-clinicopathologic features affecting outcome. Cancer. 2012;118(1):101-111. doi:10.1002/cncr.26229
Zumsteg ZS, Luu M, Kim S, et al. Quantitative lymph node burden as a ‘very-high-risk’ factor identifying head and neck cancer patients benefiting from postoperative chemoradiation. Ann Oncol. 2019;30(1):76-84. doi:10.1093/annonc/mdy490
Ansarin M, Bruschini R, Navach V, et al. Classification of GLOSSECTOMIES: proposal for tongue cancer resections. Head Neck. 2019;41(3):821-827. doi:10.1002/hed.25466
Tagliabue M, Gandini S, Maffini F, et al. The role of the T-N tract in advanced stage tongue cancer. Head Neck. 2019;41(8):2756-2767. doi:10.1002/hed.25761
Thoeny HC, De Keyzer F, King AD. Diffusion-weighted MR imaging in the head and neck. Radiology. 2012;263(1):19-32. doi:10.1148/radiol.11101821
García J, López M, López L, et al. Validation of the pathological classification of lymph node metastasis for head and neck tumors according to the 8th edition of the TNM classification of malignant tumors. Oral Oncol. 2017;70:29-33. doi:10.1016/j.oraloncology.2017.05.003
Wang F, Tan R, Feng K, et al. Magnetic resonance imaging-based radiomics features associated with depth of invasion predicted lymph node metastasis and prognosis in tongue cancer. J Magn Reson Imaging. 2021;56:196-209. doi:10.1002/jmri.28019
Frood R, Palkhi E, Barnfield M, Prestwich R, Vaidyanathan S, Scarsbrook A. Can MR textural analysis improve the prediction of extracapsular nodal spread in patients with oral cavity cancer? Eur Radiol. 2018;28(12):5010-5018. doi:10.1007/s00330-018-5524-x
Ren J, Qi M, Yuan Y, Tao X. Radiomics of apparent diffusion coefficient maps to predict histologic grade in squamous cell carcinoma of the oral tongue and floor of mouth: a preliminary study. Acta Radiol. 2021;62(4):453-461. doi:10.1177/0284185120931683
Yu B, Huang C, Xu J, et al. Prediction of the degree of pathological differentiation in tongue squamous cell carcinoma based on radiomics analysis of magnetic resonance images. BMC Oral Health. 2021;21(1):585. doi:10.1186/s12903-021-01947-9
Li R, Li L, Xu Y, Yang J. Machine learning meets omics: applications and perspectives. Brief Bioinform. 2021;23(1):bbab460. doi:10.1093/bib/bbab460

Auteurs

Chiara Mossinelli (C)

Department of Otorhinolaryngology and Head and Neck Surgery, European Institute of Oncology, IRCCS, Milan, Italy.

Marta Tagliabue (M)

Department of Otorhinolaryngology and Head and Neck Surgery, European Institute of Oncology, IRCCS, Milan, Italy.
Department of Biomedical Sciences, University of Sassari, Sassari, Italy.

Francesca Ruju (F)

Division of Radiology, IEO, European Institute of Oncology, IRCCS, Milan, Italy.

Giulio Cammarata (G)

Department of Experimental Oncology, IEO European Institute of Experimental Oncology IRCCS, Milan, Italy.

Stefania Volpe (S)

Division of Radiation Oncology, European Institute of Oncology, IRCCS, Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

Sara Raimondi (S)

Department of Experimental Oncology, IEO European Institute of Experimental Oncology IRCCS, Milan, Italy.

Mattia Zaffaroni (M)

Division of Radiation Oncology, European Institute of Oncology, IRCCS, Milan, Italy.

Johannes Lars Isaksson (JL)

Division of Radiation Oncology, European Institute of Oncology, IRCCS, Milan, Italy.

Cristina Garibaldi (C)

Unit of Radiation Research, IEO European Institute of Oncology, IRCCS, Milan, Italy.

Marta Cremonesi (M)

Unit of Radiation Research, IEO European Institute of Oncology, IRCCS, Milan, Italy.

Federica Corso (F)

Department of Experimental Oncology, IEO European Institute of Experimental Oncology IRCCS, Milan, Italy.
Department of Mathematics (DMAT), Politecnico di Milano, Milan, Italy.
Centre for Health Data Science (CHDS), Human Techonopole.

Aurora Gaeta (A)

Department of Experimental Oncology, IEO European Institute of Experimental Oncology IRCCS, Milan, Italy.

Ilaria Emili (I)

Division of Radiology, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
ASST Centro Specialistico Ortopedico Traumatologico G. Pini/C.T.O, Milan, Italy.

Stefano Zorzi (S)

Department of Otorhinolaryngology and Head and Neck Surgery, European Institute of Oncology, IRCCS, Milan, Italy.

Daniela Alterio (D)

Division of Radiation Oncology, European Institute of Oncology, IRCCS, Milan, Italy.

Giulia Marvaso (G)

Division of Radiation Oncology, European Institute of Oncology, IRCCS, Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

Matteo Pepa (M)

Division of Radiation Oncology, European Institute of Oncology, IRCCS, Milan, Italy.

Elvio De Fiori (E)

Division of Radiology, IEO, European Institute of Oncology, IRCCS, Milan, Italy.

Fausto Maffini (F)

Division of Pathology, IEO, European Institute of Oncology, IRCCS, Milan, Italy.

Lorenzo Preda (L)

Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy.
Division of Radiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Marco Benazzo (M)

Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy.
Department of Otorhinolaryngology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Barbara Alicja Jereczek-Fossa (BA)

Division of Radiation Oncology, European Institute of Oncology, IRCCS, Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

Mohssen Ansarin (M)

Department of Otorhinolaryngology and Head and Neck Surgery, European Institute of Oncology, IRCCS, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH